Stabilization of solid thyroid drug formulations
CA 2641575 C · Owner: Sigmapharm, Inc. · Inventors: Spireas, Spiridon
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a drug dosage form prepared by compression techniques comprising: a substantially non- volatile pharmaceutically acceptable oil, a pharmaceutically acceptable excipient and a thyroid drug treated with the substantially non-volatile pharmaceutically acceptable oil to substantially waterproof the thyroid drug; the drug dosage form prepared by: (a) dispersing the thyroid drug and the exciepient in the substantially non-volatile pharmaceutically acceptable oil; and (b) compacting the thyroid drug into dosage forms using compression pressures of up to 5,000 psi/g. The dosage form may be used for treating a patient in need of thyroid replacement therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 26, 2001 and granted April 8, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.